Use este identificador para citar ou linkar para este item: https://repositorio.bahiana.edu.br:8443/jspui/handle/bahiana/3049
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorSouza, Juliana Sacramento Mota de-
dc.contributor.authorCunha, JP Monteiro-
dc.contributor.authorSouza, JSM de-
dc.contributor.authorDiaz, RS-
dc.contributor.authorRego, FF de Almeida-
dc.contributor.authorAndrade, E-
dc.contributor.authorSilva, MO-
dc.contributor.authorM, Giovanetti-
dc.contributor.authorOliveira, T de-
dc.contributor.authorOliveira, A-
dc.contributor.authorBrites, RC-
dc.contributor.authorAlcantara, LC-
dc.date.accessioned2019-07-12T14:43:28Z-
dc.date.available2019-07-12T14:43:28Z-
dc.date.issued2017-06-17-
dc.identifier.issn2454-499-
dc.identifier.numberVol. 3. Nº 1pt_BR
dc.identifier.urihttp://www7.bahiana.edu.br//jspui/handle/bahiana/3049-
dc.description.abstractThe distribution of different human immunodeficiency virus type 1 (HIV-1) genotypes and the prevalence of transmitted drug resistance (TDR) mutations vary greatly across different Brazilian regions. This study aimed to describe the HIV-1 molecular diversity and TDR prevalence among treatment-naïve HIV-1 infected individuals in an urban area of Northeastern Brazil. DNA samples from 97 infected individuals were obtained and pol sequences were generated by Polimerase Chain Reaction (PCR) and direct sequencing. Bioinformatics tools were used to identify the presence of associated mutations with drug resistance, to reconstruct the phylogeny and to detect recombination. The median age and estimated time of HIV-1 diagnosis were 34 years and 12 months, respectively and 61% of the patients were male. The main exposure category was sexual (87.5%) and the median TCD4+ lymphocyte counts and viral load were 438 cells/mm3 and 4.4 log10, respectively. The overall TDR prevalence was 5.1% while within each drug class (Non-nucleoside reversetranscriptase inhibitors - NNRTIs, Nucleoside analog reverse-transcriptase inhibitors - NRTIs and Protease inhibitors - PIs) this rate was 2.1% individually. These TDR mutations confer intermediate to high-level resistance to different drugs that are used as first-line treatment options, which reinforce the importance of genotype testing prior to treatment initia-tion. Phylogenetic analysis showed that 73.2% of the samples were subtype B, 14.4% were subtype F, 4.1% were subtype C and 8.3% were BF recombinants. Our data indicate that the genotypic profile of HIV-1 strains circulating in Bahia is diversified and show an increase of subtype C prevalence in Northeast Brazil.pt_BR
dc.language.isoenpt_BR
dc.sourcehttp://www.annexpublishers.co/full-text/JAHI/3103/HIV-1-Molecular-Characterization-and-Transmitted-Drug-Resistance-Prevalence-among-Treatment-Naive-Individuals.phppt_BR
dc.subjectGenotyping; Mutation; Antiretroviral; Subtypes; HIV; Resistance; Prevalence.pt_BR
dc.titleHIV-1 molecular characterization and transmitted drug resistance prevalence among treatment-naïve individualspt_BR
dc.title.alternativeJournal of AIDS and HIV infectionspt_BR
dc.typeProdução bibliográfica: Artigos completos publicados em periódicospt_BR
Aparece nas coleções:Artigos Completos Publicados em Periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO - JULIANA SACRAMENTO - 2017.pdf2,18 MBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.